Secondary Antiphospholipid Syndrome with Recurring Acute Coronary Events

Authors

  • Sofia Metaxa Evagelismos Hospital, Athens
  • Kostas Bronis Evagelismos Hospital, Athens
  • Prokopis Stroumpoulis Evagelismos Hospital, Athens
  • Spyridon Koulouris Evagelismos Hospital, Athens
  • Antonis S Manolis Evagelismos General Hospital, Athens

DOI:

https://doi.org/10.2015/hc.v8i2.533

Keywords:

acute coronary syndrome, acute myocardial infarction, coronary thrombosis, antiphospholipid syndrome, anticardiolipin antibodies, anticoagulation

Abstract

A 41-year-old gentleman with a recent history of Hodgkin’s lymphoma sustained an acute inferior wall myocardial infarction, managed with percutaneous coronary intervention, thromboaspiration and stenting in a totally occluded right coronary artery. He was placed on triple antithrombotic treatment with dual antiplatelet therapy and oral anticoagulation because of a large thrombotic load in the right coronary artery. Three months later and 5 days after discontinuation of prescribed oral anticoagulant, he had a new acute coronary event due to acute reocclusion in the right coronary artery. Thrombus aspiration and repeat angioplasty restored vessel patency. The patient was put back on triple antithrombotic therapy and was investigated for uncommon causes of blood hypercoagulability. Blood assays revealed elevated anti-β2 glycoprotein I (anti-β2GPI) (IgM) and anticardiolipin antibodies (IgM), consistent with a diagnosis of secondary antiphospholipid syndrome.

Author Biography

Antonis S Manolis, Evagelismos General Hospital, Athens

Specialty: Cardiology

Downloads

Additional Files

Published

2013-04-07

Issue

Vol. 8 No. 2 (2013)

Section

CASE REPORTS

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).